Does ELOTUZUMAB Cause Oedema peripheral? 29 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 29 reports of Oedema peripheral have been filed in association with ELOTUZUMAB (EMPLICITI). This represents 0.8% of all adverse event reports for ELOTUZUMAB.
29
Reports of Oedema peripheral with ELOTUZUMAB
0.8%
of all ELOTUZUMAB reports
14
Deaths
15
Hospitalizations
How Dangerous Is Oedema peripheral From ELOTUZUMAB?
Of the 29 reports, 14 (48.3%) resulted in death, 15 (51.7%) required hospitalization, and 4 (13.8%) were considered life-threatening.
Is Oedema peripheral Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ELOTUZUMAB. However, 29 reports have been filed with the FAERS database.
What Other Side Effects Does ELOTUZUMAB Cause?
Plasma cell myeloma (339)
Death (234)
Malignant neoplasm progression (227)
Pneumonia (209)
Pyrexia (183)
Drug ineffective (137)
Neutropenia (133)
Anaemia (119)
Thrombocytopenia (107)
Diarrhoea (105)
What Other Drugs Cause Oedema peripheral?
AMBRISENTAN (2,959)
TREPROSTINIL (2,816)
ADALIMUMAB (2,356)
LENALIDOMIDE (2,298)
AMLODIPINE (2,076)
PREDNISONE (2,029)
METHOTREXATE (1,939)
MACITENTAN (1,932)
RITUXIMAB (1,698)
TOCILIZUMAB (1,574)
Which ELOTUZUMAB Alternatives Have Lower Oedema peripheral Risk?
ELOTUZUMAB vs ELOXATIN
ELOTUZUMAB vs ELRANATAMAB
ELOTUZUMAB vs ELRANATAMAB-BCMM
ELOTUZUMAB vs ELTROMBOPAG
ELOTUZUMAB vs ELTROMBOPAG OLAMINE